Table 4 Average cost-effectiveness ratios of interventions
From: Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
Intervention | Average cost-effectiveness ratio | |||
|---|---|---|---|---|
| Â | Tx 1 | Tx+Hosp 2 | Tx+Time 3 | Total |
Typical | 64,000 | Dominant4 | 87,000 | Dominant |
Risperidone | 66,000 | Dominant | 85,000 | Dominant |
Olanzapine | 1,100,000 | 980,000 | 1,100,000 | 1,000,000 (730,000; 1,400,000) |
Clozapine | 80,000 | Dominant | 130,000 | 12,000 (Dominant; 38,000) |
FI5 + Risperidone | 42,000 | Dominant | 57,000 | Dominant |
Risperidone (2/3) & Clozapine (1/3)6 + FI | 45,000 | Dominant | 67,000 | Dominant |